Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Health Care Reform and Business Development: 10 Reasons It Matters

Oct 01 2009

Related Content

The Part D Peak: Big Pharma's Blowout Quarter

May 01 2007

Living in a Bipolar World: Implications of the EPO Safety Debate (Part 1)

Jul 01 2007

Mind Your Bs and Ds

Jun 01 2006

Big Pharma May Be Big Player in Follow-On Biologics Market

Apr 01 2008

A Cold Shower For Viagra: How Congress Can Chill A Market

Dec 01 2005

Cost Effectiveness in the US? Round One Goes Against Pharma

Apr 01 2009

Abbott Buys Solvay Pharma Unit But Is It Just A Short-Term Fix?

Sep 28 2009

Limiting Cost-sharing on Drugs: A Big PhRMA Objective from Health Reform

Aug 01 2009

Pfizer/Wyeth: Industrializing Pharma?

Feb 01 2009

Dollars for Donuts: Inside the Key Elements of PhRMA's Health Reform Deal

Jun 01 2009

Tight Credit Renews Interest In Lowering Tax On Repatriated Income

Feb 09 2009

MedPAC On Steroids: The Implications of a New Medicare Advisory Council

Jul 01 2009

Related Companies

Pfizer Inc.

Wyeth

Johnson & Johnson

Abbott

Elan Corporation

Johnson & Johnson

Solvay SA

Bayer AG

Merck & Co., Inc.

Schering-Plough

Allergan plc

Novartis AG

Additional Topics

Business Strategies Regulation Reimbursement BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window